China Universal Asset Management »

Dyne Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $694k 19k 35.92
2024-06-30 $406k 12k 35.29
2024-03-31 $442k 16k 28.39
2023-12-31 $94k 7.1k 13.30
2023-09-30 $14k 1.6k 8.96
2023-06-30 $8.6k 764 11.25
2023-03-31 $8.1k 706 11.52
2022-12-31 $6.1k 530 11.59
2022-09-30 $6.0k 484 12.40

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics